International Journal of Epidemiology 2001;30:894-895
© International Epidemiological Association 2001
Infectious Disease |
Commentary: Control of Chagas' disease: let's put people before vectors
Facultad de Medicina, Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
| The first 10% of the full text of this article appears below. |
| Introduction |
|---|
Chagas' disease (CHAD), the result of the human infection by Trypanosoma cruzi remains a major disease burden in Latin America. A relatively high proportion (30%) of the 1618 million infected individuals in the so-called indeterminate phase tend to progress to the chronic phase, mainly a dilated cardiomyopathy, which appears as early as in the third or fourth decade of life.1 Chagas' disease contributes to approximately 2 740 000 disability-adjusted life years lost, four times the overall burden of malaria, schistosomiasis, leprosy and leishmaniasis in the continent.2 In the absence of suitable vaccination, chemoprophylaxis or specific treatment, the only
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Lima-Costa, S. Barreto, H. Guerra, and J. C Villar Chagas' disease among older adults: branches or mainstream of the present burden of Trypanosoma cruzi infection? Int. J. Epidemiol., June 1, 2002; 31(3): 688 - 689. [Full Text] [PDF] |
||||
